Skip to main content
Vivimed Labs Ltd. logo

Vivimed Labs Ltd. — Investor Relations & Filings

Ticker · VIVIMEDLAB ISIN · INE526G01021 LEI · 335800LYN9TN3F87WV86 BSE.NS Manufacturing
Open in API
Filings indexed 860 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country IN India
Listing BSE.NS VIVIMEDLAB

About Vivimed Labs Ltd.

http://www.vivimedlabs.com/

Vivimed Labs Ltd. specializes in the development and manufacture of active pharmaceutical ingredients (APIs), finished dosage formulations (FDF), and specialty chemicals. The company provides contract research and manufacturing services (CRAMS) and produces generic medicines across various therapeutic areas. Its specialty chemicals division focuses on niche products, including photochromic dyes for ophthalmic lenses, hair colorants, and anti-microbial agents for personal care and industrial use. Vivimed operates research and development centers and manufacturing facilities that adhere to international regulatory standards, catering to a global customer base in the healthcare and chemical sectors.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 92% confidence The document is titled 'Annual Secretarial Compliance Report' issued by the Company Secretary under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and submitted to BSE and NSE. It is a regulatory compliance certification rather than the full annual report or any financial statements. Under the CERTIFICATION RULE, such officer attestations or compliance certificates are classified as Regulatory Filings (RNS).
2026-05-19 English
annual secretarial compliance report
Regulatory Filings Classification · 76% confidence The document is an "Annual Secretarial Compliance Report" filed under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a compliance certificate issued by a Practicing Company Secretary on statutory and listing regulation adherence, not a quantitative financial report, management discussion, earnings release or annual report. It contains no financial statements or substantive performance data; rather it certifies regulatory compliance. This falls under the general “Regulatory Filings” category for miscellaneous compliance and certification documents that do not fit other specialized report types.
2026-05-19 English
Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve audited results for FY 2025-2026
Regulatory Filings Classification · 92% confidence The document is a notice under SEBI Listing Regulations to BSE and NSE about an upcoming Board of Directors meeting to consider and approve audited financial results. It does not contain any financial statements or results itself, nor does it announce changes in board membership or issue other specific items. It is a general regulatory announcement of a board meeting date, which does not fit a more specific category. Therefore, it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-17 English
Corporate Insolvency Resolution Process
Regulatory Filings
2026-04-23 English
Form A - Public Announcement
Regulatory Filings
2026-04-23 English
Corporate Insolvency Resolution Process
Regulatory Filings
2026-04-17 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.